Farrukh Awan
@awandoc
Leukemia | CLL l Targeted therapy | Views are my own, retweet does not mean endorsement
162 Following 179 Followers 32 Posts
Latest posts 5
International Consensus Statement on the Management of Cardiovascular Risk of Bruton's Tyrosine Kinase Inhibitors in CLL ashpublications.org/bloodadvances/…
ashpublications.org International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine... Abstract. Bruton’s tyrosine kinase inhibitors (BTKis) have altered the treatment landscape for chronic lymphocytic leukemia (CLL) by offering effective and 
pubmed.ncbi.nlm.nih.gov NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022... The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years. Targeted therapy with Bruton's tyrosine kinase (BTK) inhibitors... A Criticism of the Career Critics facebook.com/BloodCancersTo…
Looking forward to the @PatientPower CLL summit in Arlington on Saturday